A vaccine including recombinant vaccinia virus (ATCC VR-1354) having an inserted gene for coding glutamic acid decarboxylase is used for preventing type 1 diabetes mellitus. The glutamic acid decarboxylase expressed from the recombinant virus suppresses or tolerizes the autoreactive T cell, and induces immunological tolerance, thus effectively prevents or delays the development of type 1 diabetes mellitus.

 
Web www.patentalert.com

< Halogenated calixpyrroles and uses thereof

< Method and system for myocardial infarction repair

> Progenitor cell preservation factors and methods for and products of their use

> Herbal medicaments for the treatment of neurocerebrovascular disorders
~ 00235